Abstract:5-Flucytosine (5-FC) could be changed to 5-fluorouracil (5-FU) by cytosine deaminase (CD), the latter is able to kill cancer cells. However, there is no efficient method to deliver the CD gene into the tumor cells, which hampers the application of the suicide gene system. In this experiment, for the first time, the NDV has been utilized as a vector to deliver the CD gene into the cancer cells, the virus can infect the cancer cells specifically, replicate and assemble, while the cytosine deaminase is expressed. Then the CD converts the prodrug 5-FC into 5-FU to achieve the purpose of inhibiting tumor. Firstly, the whole genome of E. coli JM109 was extracted, and the CD gene was obtained by cloning method. Then the CD and IRES-EGFP were ligated into the pEE12.4 expression vector to become a recombinant pEE12.4IE-CD eukaryotic expression plasmid. The human liver cancer cells were transfected with the plasmid. The cells were treated with different concentrations of 5-FC, MTT method was used to determine the killing effect of CD/5-FC system on the human liver cancer cells. The cell deaths were 18.07%, 42.98% and 62.20% respectively when the concentrations of prodrug were at 10, 20 and 30 mmol x L(-1). In 5-FC acute toxicity experiment, Kunming mice were injected with different concentrations of 5-FC at intervals of 1:0.5. The LD50 of 5-FC through iv injection was determined by improved Karber's method, the LD50 was 507 mg x kg(-1) and the 95% confidence limit was 374-695 mg x kg(-1). According to the maximum LD0 dose of the LD50, the maximum safe dose was 200 mg x kg(-1). Body weight and clinic symptoms of the experimental animals were observed. These results laid the foundation to verify the antitumor effect and safety of CD/5-FC system in animal models. The CD gene was ligated into the NDV (rClone30) carrier, then the tumor-bearing animal was established to perform the tumor inhibiting experiment. The result showed that the recombinant rClone30-CD/5-FC system has a high antitumor activity in vivo. To summarize, CD gene has been cloned and its bioactivity has been confirmed in the mammalian cells. It is the first time in this study to utilize the recombinant NDV to deliver the CD gene into the tumor cells; our result proves the rClone30-CD/5-FC system is a potential method for cancer therapy.

Transduction of Cytosine Deaminase Gene Makes Rat Glioma Cells Highly Sensitive to 5-Fluorocytosine

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

Killing effect of mutant herpes simplex virus type 1 thymidine kinase on rat C6 glioma cells

In Vivo Replication-Deficient Adenovirus Vector-Mediated Transduction of the Cytosine Deaminase Gene Sensitizes Glioma Cells to 5-Fluorocytosine.

Antitumor Efficiency of the Cytosine Deaminase/5-Fluorocytosine Suicide Gene Therapy System on Malignant Gliomas: an in Vivo Study.

Inhibitory Effects of Cytosine Deaminase Gene-Transfected Bone Marrow Mesenchymal Stem Cells on Glioma Cell Proliferation

Antitumor efficacy of cytosine deaminase/5-fluorocytosine suicide gene therapy system against Inalignant gliomas in nude mice

Anti Tumor Effect of Cytosine Deaminase Gene on Gastric Cancer Cells

Adenovirus-mediated Tissue-Specific Cytosine Deaminase Gene Therapy for Human Hepatocellular Carcinoma with Different AFP Expression Levels.

The Antitumor Effect of Mesenchymal Stem Cells Transduced with a Lentiviral Vector Expressing Cytosine Deaminase in a Rat Glioma Model

Experimental expression study of liposome mediated cytosine deaminase suicide gene transfecting SHG-44 malignant brain gliom cells

Apoptosis induced by 5-fluorocytosine in SHG-44 human malignant glioma cells genetically modified to express cytosine deaminase

Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter.

Experimental study on the anti-malignant glioma effect of HSV-tk/GCV suicide gene therapy system enhanced by Cx43 gene

[Antitumor Activity of the Recombinant Rclone30-Cd/5-fc System].

In Vivo Growth of Cerebral C6 Glioma Cells Transfected and Treated with CX43 Gene

Effective and Safe Gene Therapy for Colorectal Carcinoma Using the Cytosine Deaminase Gene Directed by the Carcinoembryonic Antigen Promoter.

A Safe, Effective in Vivo Gene Therapy for Melanoma Using Tyrosinase Promoter-Driven Cytosine Deaminase Gene

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

Enhancement of anti-tumor activity of Newcastle disease virus by the synergistic effect of cytosine deaminase.

An Vitro study on killing maglinant glioma cell by human peripheral blood EPCs transfected with suicide gene